A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.
Y
Y
Boumber
H
H
Kantarjian
J
J
Jorgensen
S
S
Wen
S
S
Faderl
R
R
Castoro
J
J
Autry
G
G
Garcia-Manero
G
G
Borthakur
E
E
Jabbour
Z
Z
Estrov
J
J
Cortes
J-P
JP
Issa
F
F
Ravandi
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine